Skip to main content
. 2022 Feb 11;9:803650. doi: 10.3389/fcvm.2022.803650

Table 4.

Demography of angiographic findings and outcome among groups.

Variable Study groups P -value
Smoker (N = 741) Non-smoker (N = 1,303)
Follow-up time (months) 49.3 ± 33.5 48.0 ± 37.4 0.43
Number of diseased vessel 0.21
   Single vessel disease 379 (51.2%) 717 (55.0%)
   Dual vessel disease 211 (28.5%) 331 (25.4%)
   Triple vessel disease 151 (20.4%) 255 (19.6%)
Mean of treated vessels 1.2 ± 0.4 1.2 ± 0.4 0.35
Mean of treated lesions 1.4 ± 0.7 1.3 ± 0.7 0.23
SYNTAX score 11.5 ± 8.3 10.8 ± 7.9 0.04
LVEF 0.60 ± 0.10 0.60 ± 0.10 0.39
Type of intervention <0.01*
   Balloon angioplasty 144 (19.4%) 332 (25.5%)
   BMS deployment 306 (41.3%) 397 (30.5%)
   DES deployment 291 (39.3%) 574 (44.0%)
MI 0.07
   Yes 19 (2.6%) 52 (4.0%)
   No 722 (97.4%) 1251 (96.0%)
CV death <0.01*
   Yes 44 (5.9%) 124 (9.5%)
   No 697 (94.1%) 1179 (90.5%)
All-cause death <0.01*
   Yes 72 (9.7%) 195 (15.0%)
   No 669 (90.3%) 1108 (85.0%)
Repeat PCI <0.01*
   Yes 232 (31.3%) 316 (24.3%)
   No 509 (68.7%) 987 (75.7%)

BMS, bare metal stent; DES, drug-eluting stent; LVEF, left ventricular ejection fraction; MI, myocardial infarction; Repeat PCI, repeated percutaneous coronary intervention; SYNTAX score, Synergy between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery score.

*

significant.